Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ekso Bionics Holdings Inc (EKSO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 103,359
  • Shares Outstanding, K 62,642
  • Annual Sales, $ 7,350 K
  • Annual Income, $ -29,120 K
  • 36-Month Beta 0.73
  • Price/Sales 9.59
  • Price/Cash Flow N/A
  • Price/Book 18.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +46.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.23 +34.15%
on 12/31/18
1.83 -9.84%
on 01/04/19
+0.25 (+17.86%)
since 12/21/18
3-Month
1.23 +34.15%
on 12/31/18
2.25 -26.67%
on 11/12/18
-0.37 (-18.32%)
since 10/22/18
52-Week
1.23 +34.15%
on 12/31/18
3.30 -50.00%
on 08/15/18
-0.08 (-4.62%)
since 01/22/18

Most Recent Stories

More News
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and...

EKSO : 1.65 (-1.20%)
Ekso Bionics(R) Secures Purchase Orders for the EksoVest(TM) from Two Global Aerospace Manufacturers

Aerospace Industry Leaders Piloting Wearable Exoskeleton to Enhance Worker Safety, and Reduce Fatigue and Risk of Injury on Assembly Production Lines of Commercial and Defense Airplanes

EKSO : 1.65 (-1.20%)
Worldwide Adoption of Ekso Bionics(R) EksoGT(TM) Exoskeleton Allows Stroke and Spinal Cord Injury Patients to Take 100 Million Steps to Date

More than 240 leading rehabilitation centers in over 30 countries helped their patients walk 50,000 miles in the EksoGT exoskeleton during rehab sessions-- the distance of walking around the world twice...

EKSO : 1.65 (-1.20%)
Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -22.22% and -10.87%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

EKSO : 1.65 (-1.20%)
Ekso Bionics: 3Q Earnings Snapshot

RICHMOND, Calif. (AP) _ Ekso Bionics Holdings Inc. (EKSO) on Wednesday reported a loss of $7 million in its third quarter.

EKSO : 1.65 (-1.20%)
Ekso Bionics Appoints Thomas Schreck to its Board of Directors

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Thomas Schreck to its Board of Directors, effective...

EKSO : 1.65 (-1.20%)
Report: Exploring Fundamental Drivers Behind Presidio, NACCO Industries, Ekso Bionics, SAExploration, American Software, and A-Mark Precious Metals -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Presidio, Inc. (NASDAQ:PSDO),...

EKSO : 1.65 (-1.20%)
NC : 36.38 (-2.23%)
SAEX : 4.10 (unch)
AMSWA : 10.91 (+0.18%)
PSDO : 14.84 (-0.20%)
AMRK : 13.02 (-1.21%)
Ekso Bionics to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2018

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Peurach, President and Chief Executive Officer of Ekso...

EKSO : 1.65 (-1.20%)
Gait Trainer Market Will Hit at a CAGR of 4.9% From 2018 to 2028 - Future Market Insights

The global market for gait trainers is being progressively influenced by the growing competition and the expansion of the walking aids industry. The rising number of spinal injuries as well as strokes...

EKSO : 1.65 (-1.20%)
Ekso Bionics: 1Q Earnings Snapshot

RICHMOND, Calif. (AP) _ Ekso Bionics Holdings Inc. (EKSO) on Monday reported a loss of $7.9 million in its first quarter.

EKSO : 1.65 (-1.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade EKSO with:

Business Summary

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western...

See More

Key Turning Points

2nd Resistance Point 1.80
1st Resistance Point 1.72
Last Price 1.65
1st Support Level 1.60
2nd Support Level 1.56

See More

52-Week High 3.30
Fibonacci 61.8% 2.51
Fibonacci 50% 2.26
Fibonacci 38.2% 2.02
Last Price 1.65
52-Week Low 1.23

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar